Lguratimod

Product introduction:

Iguratimod, chemical name is n - [3 - (formamido) - 4-oxy-6-phenoxy-4h-1-benzopyran-7-yl] methanesulfonamide, white or almost white crystalline powder, odorless, tasteless, insoluble in water, slightly soluble in acetonitrile, soluble in dichloromethane, tetrahydropyran, chloroform and ethanol. It is a new anti rheumatic drug for alleviating the disease, which can alleviate the joint injury and immune abnormalities of chronic arthritis and autoimmune diseases, and inhibit the production of inflammatory cytokines and immunoglobulin. It has significant effect and safety in the treatment of rheumatoid arthritis. It shows anti-inflammatory and analgesic effects on acute and chronic inflammation. Different from traditional non steroidal anti-inflammatory drugs, eilamod basically does not show ulcer adverse reactions in the digestive tract. This product can activate osteoclasts, promote bone absorption and lead to bone loss, Inhibition of these proinflammatory factors can control rheumatoid arthritis and bone loss.

CAS：123663-49-0

Molecular formula: C₁₇H₁₄N₂O₆S

Molecular weight: 374.37

Structural type:

Adverse reactions: This product has high safety and no serious adverse reactions. The discomfort symptoms are mainly mild gastrointestinal discomfort. The symptoms are not serious. It will not affect the patient's continued treatment after appropriate treatment.